Page 1 of Clinical Trials for clinical trial phase I, 30974 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Evaluating Patient Participation in Phase I Clinical Trials
Last Updated: March 14, 2012
Condition(s): Psychosocial Effects of Cancer and Its Treatment; Unspecified Adult Solid Tumor, Protocol Specific
2
Suspended
A Phase I Study of Pyrimethamine in Patients With GM-2 Gangliosidosis
Last Updated: October 1, 2008
Condition(s): G(M2) Ganglioside; Tay-Sachs Disease Ganglioside; Sandhoff Disease Ganglioside
3
Active, not recruiting
Post Ten Year Follow up Assessment of a Phase I Trial of Angiogenic Gene Therapy
Last Updated: August 9, 2011
Condition(s): Coronary Artery Disease; Ischemia
4
Completed
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
Last Updated: January 26, 2007
Condition(s): Tuberculosis
5
Completed
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously
Last Updated: January 26, 2007
Condition(s): Tuberculosis
6
Not yet recruiting
Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies
Last Updated: March 9, 2012
Condition(s): Solid Tumor
7
Active, not recruiting
Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
Last Updated: November 10, 2011
Condition(s): Multiple Myeloma
8
Active, not recruiting
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Last Updated: May 18, 2011
Condition(s): Resistant Solid Malignancies
9
Active, not recruiting
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
Last Updated: May 18, 2011
Condition(s): Resistant Solid Malignancies
10
Completed
Survey of the Use of Alternative Medical Therapies in Adult Cancer Patients Enrolled in Phase I Clinical Trials
Last Updated: March 3, 2008
Condition(s): Neoplasm
11
Not yet recruiting
Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT
Last Updated: August 18, 2008
Condition(s): Allogeneic Transplantation (Non T-Cell Depleted)
12
Enrolling by invitation
Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers
Last Updated: January 30, 2012
Condition(s): Rheumatoid Arthritis
13
Recruiting
Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
Last Updated: June 22, 2010
Condition(s): Multiple Myeloma
14
Recruiting
Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials
Last Updated: May 3, 2012
Condition(s): Advanced Malignancy
15
Recruiting
Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells
Last Updated: September 21, 2010
Condition(s): Metastatic Melanoma; Absence of CNS Metastases
16
Completed
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
Last Updated: May 19, 2012
Condition(s): Small Cell Carcinoma; Mesothelioma; Non-Small-Cell Lung Carcinoma
17
Recruiting
Phase 1 Clinical Trial in Patients With Advanced Malignancies
Last Updated: April 18, 2012
Condition(s): Advanced Malignancies
18
Recruiting
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
Last Updated: May 23, 2011
Condition(s): Amaurosis of Leber; Retinal Diseases
19
Completed
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma
Last Updated: April 18, 2012
Condition(s): Cancer; Lymphomas
20
Completed
A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid Malignancies
Last Updated: May 9, 2012
Condition(s): Solid Malignancies

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=clinical+trial+phase+I

Page 1 of Clinical Trials for clinical trial phase I, 30974 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About